Stringer JS - Search Results

1

Nevirapine to prevent mother-to-child transmission of HIV-1 among women of unknown serostatus.

Stringer JS, Rouse DJ, Sinkala M, Marseille EA, Vermund SH, Stringer EM, Goldenberg RL. Stringer JS, et al. Among authors: stringer em. Lancet. 2003 Nov 29;362(9398):1850-3. doi: 10.1016/S0140-6736(03)14907-0. Lancet. 2003. PMID: 14654326 Review. No abstract available.

2

Prophylactic cesarean delivery for the prevention of perinatal human immunodeficiency virus transmission: the case for restraint.

Stringer JS, Rouse DJ, Goldenberg RL. Stringer JS, et al. JAMA. 1999 May 26;281(20):1946-9. doi: 10.1001/jama.281.20.1946. JAMA. 1999. PMID: 10349900 No abstract available.

3

Rapid testing and zidovudine treatment to prevent vertical transmission of human immunodeficiency virus in unregistered parturients: a cost-effectiveness analysis.

Stringer JS, Rouse DJ. Stringer JS, et al. Obstet Gynecol. 1999 Jul;94(1):34-40. doi: 10.1016/s0029-7844(99)00243-4. Obstet Gynecol. 1999. PMID: 10389714

4

Prevention of mother-to-child transmission of HIV in Thailand: physicians' attitudes on zidovudine use, pregnancy termination, and willingness to provide care.

Stringer JS, Stringer EM, Phanuphak P, Jetwana P, Reinprayoon D, Funkhouser EM, Vermund SH. Stringer JS, et al. Among authors: stringer em. J Acquir Immune Defic Syndr. 1999 Jul 1;21(3):217-22. doi: 10.1097/00126334-199907010-00006. J Acquir Immune Defic Syndr. 1999. PMID: 10421245

5

Prevention of mother-to-child transmission of HIV-1.

Stringer JS, Vermund SH. Stringer JS, et al. Curr Opin Obstet Gynecol. 1999 Oct;11(5):427-34. doi: 10.1097/00001703-199910000-00003. Curr Opin Obstet Gynecol. 1999. PMID: 10526917 Review.

6

An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes.

Rouse DJ, Stringer JS. Rouse DJ, et al. Among authors: stringer js. Am J Obstet Gynecol. 2000 Aug;183(2):400-6. doi: 10.1067/mob.2000.105967. Am J Obstet Gynecol. 2000. PMID: 10942477

7

Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa.

Stringer JS, Rouse DJ, Vermund SH, Goldenberg RL, Sinkala M, Stinnett AA. Stringer JS, et al. J Acquir Immune Defic Syndr. 2000 Aug 1;24(4):369-77. doi: 10.1097/00126334-200008010-00012. J Acquir Immune Defic Syndr. 2000. PMID: 11015154

8

Subclinical chorioamnionitis as a targetable risk factor for vertical transmission of HIV-1.

Stringer JS, Goldenberg RL. Stringer JS, et al. Ann N Y Acad Sci. 2000 Nov;918:77-83. doi: 10.1111/j.1749-6632.2000.tb05476.x. Ann N Y Acad Sci. 2000. PMID: 11131737 Review. No abstract available.

9

Zambian women's attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV.

Sinkala M, Stout JP, Vermund SH, Goldenberg RL, Stringer JS. Sinkala M, et al. Among authors: stringer js. Lancet. 2001 Nov 10;358(9293):1611-2. doi: 10.1016/S0140-6736(01)06662-4. Lancet. 2001. PMID: 11716891

10

Evaluation of a new testing policy for human immunodeficiency virus to improve screening rates.

Stringer EM, Stringer JS, Cliver SP, Goldenberg RL, Goepfert AR. Stringer EM, et al. Among authors: stringer js. Obstet Gynecol. 2001 Dec;98(6):1104-8. doi: 10.1016/s0029-7844(01)01631-3. Obstet Gynecol. 2001. PMID: 11755561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

270 results

Search Page

Filters